The clinical efficacy and safety of nasopharyngeal airway in radiofrequency thermocoagulation of the semilunar ganglion

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15005754

Enrollment

Unknown

Registered

2014-10-31

Start date

2014-10-31

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigeminal neuralgia

Interventions

intervention group:nasopharyngeal airway

control group:face mask

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Eligible patients, older than 18 years, were suffered severe pain because of primary trigeminal neuralgia.

Exclusion criteria

Exclusion criteria: Diagnosed nasal obstruction; sleep apnea syndrome patients; patients with severe cardiovascular disease cannot tolerant operation and anesthesia;patients with hemorrhagic disease or applicating anticoagulation therapy.

Design outcomes

Primary

Measure	Time frame
VAS;	—

Countries

China

Contacts

Public ContactSong Tao

songt2001@hotmail.com+86 13304000133

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026